Tags

Type your tag names separated by a space and hit enter

Expression of CD137 and CD137 ligand in colorectal cancer patients.
Oncol Rep. 2006 May; 15(5):1197-200.OR

Abstract

The cytokine CD137, a member of the TNF receptor family, is expressed by T cells and regulates activation and proliferation of these cells. The CD137 ligand (CD137L) is expressed by antigen-presenting cells including macrophages, but also on various carcinoma cells. CD137/CD137L interaction plays a central role in sustaining T cell and macrophage activation, i.e. in antitumour immunity. The present study was designed to investigate whether CD137 and CD137L protein levels are altered in colorectal tumours compared with paired normal tissues. The CD137 and CD137L plasma levels from patients with colorectal cancer were also examined. Collectively, we noted a significantly lower CD137L level in cancerous tissue compared with paired normal tissue, and the difference in CD137L protein level was significantly lower in the colon cancer subgroup compared with paired normal colon tissue. On the other hand, we found an elevated CD137 protein level in the rectal cancer subgroup compared with paired normal rectal tissue. Patients with a tumour localised in the colon revealed significantly higher soluble CD137 protein concentration in the plasma than patients with a tumour localised in the rectum, and there was a tendency toward a higher concentration of CD137L protein in the plasma from patients with tumour localised in the colon. Moreover, the plasma concentrations of CD137 and CD137L proteins were strongly and significantly correlated. The different expression levels of CD137 and CD137L in the colon and rectum may reflect divergent mechanisms involved in the pathogenesis of colorectal cancer and lead to dissimilar protective immunity.

Authors+Show Affiliations

Department of Natural Science and Biomedicine, University College of Health Sciences, SE-551 11 Jönköping, Sweden. jan.dimberg@hhj.hj.seNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

16596186

Citation

Dimberg, Jan, et al. "Expression of CD137 and CD137 Ligand in Colorectal Cancer Patients." Oncology Reports, vol. 15, no. 5, 2006, pp. 1197-200.
Dimberg J, Hugander A, Wågsäter D. Expression of CD137 and CD137 ligand in colorectal cancer patients. Oncol Rep. 2006;15(5):1197-200.
Dimberg, J., Hugander, A., & Wågsäter, D. (2006). Expression of CD137 and CD137 ligand in colorectal cancer patients. Oncology Reports, 15(5), 1197-200.
Dimberg J, Hugander A, Wågsäter D. Expression of CD137 and CD137 Ligand in Colorectal Cancer Patients. Oncol Rep. 2006;15(5):1197-200. PubMed PMID: 16596186.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Expression of CD137 and CD137 ligand in colorectal cancer patients. AU - Dimberg,Jan, AU - Hugander,Anders, AU - Wågsäter,Dick, PY - 2006/4/6/pubmed PY - 2006/6/14/medline PY - 2006/4/6/entrez SP - 1197 EP - 200 JF - Oncology reports JO - Oncol Rep VL - 15 IS - 5 N2 - The cytokine CD137, a member of the TNF receptor family, is expressed by T cells and regulates activation and proliferation of these cells. The CD137 ligand (CD137L) is expressed by antigen-presenting cells including macrophages, but also on various carcinoma cells. CD137/CD137L interaction plays a central role in sustaining T cell and macrophage activation, i.e. in antitumour immunity. The present study was designed to investigate whether CD137 and CD137L protein levels are altered in colorectal tumours compared with paired normal tissues. The CD137 and CD137L plasma levels from patients with colorectal cancer were also examined. Collectively, we noted a significantly lower CD137L level in cancerous tissue compared with paired normal tissue, and the difference in CD137L protein level was significantly lower in the colon cancer subgroup compared with paired normal colon tissue. On the other hand, we found an elevated CD137 protein level in the rectal cancer subgroup compared with paired normal rectal tissue. Patients with a tumour localised in the colon revealed significantly higher soluble CD137 protein concentration in the plasma than patients with a tumour localised in the rectum, and there was a tendency toward a higher concentration of CD137L protein in the plasma from patients with tumour localised in the colon. Moreover, the plasma concentrations of CD137 and CD137L proteins were strongly and significantly correlated. The different expression levels of CD137 and CD137L in the colon and rectum may reflect divergent mechanisms involved in the pathogenesis of colorectal cancer and lead to dissimilar protective immunity. SN - 1021-335X UR - https://www.unboundmedicine.com/medline/citation/16596186/Expression_of_CD137_and_CD137_ligand_in_colorectal_cancer_patients_ L2 - http://www.spandidos-publications.com/or/15/5/1197 DB - PRIME DP - Unbound Medicine ER -